Seizure control in Unverricht‐Lundborg disease: a single‐centre study
- 18 June 2014
- journal article
- Published by Wiley in Epileptic Disorders
- Vol. 16 (2) , 191-195
Abstract
New antiepileptic drug (AED) options for generalised seizure types have been adopted for use as treatment for Unverricht‐Lundborg disease. Whether this has led to improved seizure control or functional outcome in ULD patients remains obscure. We retrospectively identified all patients seen at Helsinki University Hospital due to Unverricht‐Lundborg disease during 2003–2008 in order to determine which AED treatments had been retained for long‐term use. The majority of the patients had severe functional disabilities. In the year preceding the last hospital visit, all patients (n=20) were receiving polytherapy and 14 patients had been free of tonic‐clonic seizures. During follow‐up, improvement in myoclonia had been recorded for the majority of patients with either add‐on piracetam, topiramate, or levetiracetam, but valproate was still in use by all patients. Treatment with lamotrigine had been started and retained less often relative to other AEDs. Add‐on AED treatment was often associated with significant adverse effects. Unverricht‐Lundborg disease patients may benefit from add‐on treatment with levetiracetam or topiramate for seizure control. Treatment of eventual comorbidities with other than AEDs is also discussed.Keywords
This publication has 12 references indexed in Scilit:
- Unverricht-Lundborg Progressive Myoclonus Epilepsy in OmanPediatric Neurology, 2008
- Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open‐label studyEpileptic Disorders, 2008
- Substantial Thalamostriatal Dopaminergic Defect in Unverricht‐Lundborg DiseaseEpilepsia, 2007
- Lack of Efficacy and Potential Aggravation of Myoclonus with Lamotrigine in Unverricht‐Lundborg DiseaseEpilepsia, 2006
- Unverricht‐Lundborg Disease, a Condition with Self‐limited Progression: Long‐term Follow‐up of 20 PatientsEpilepsia, 2006
- Progressive myoclonic epilepsies: a review of genetic and therapeutic aspectsThe Lancet Neurology, 2005
- Add-on therapy with topiramate in progressive myoclonic epilepsyEpilepsy & Behavior, 2005
- Antimyoclonic Effect of Levetiracetam in 13 Patients with Unverricht–Lundborg Disease: Clinical ObservationsEpilepsia, 2004
- Levetiracetam in progressive myoclonic epilepsyNeurology, 2004
- Valproate and Clonazepam in the Treatment of Severe Progressive Myoclonus EpilepsyArchives of Neurology, 1982